Status:
COMPLETED
Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer
Lead Sponsor:
University of Wisconsin, Madison
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
This is a two arm, double-blind randomized study looking at the effect of zoledronate, a bisphosphonate, on the bone mineral density (BMD) of postmenopausal women with breast cancer.
Detailed Description
This is a two arm, double-blind randomized study looking at the effect of zoledronate, a bisphosphonate, on the bone mineral density (BMD) of postmenopausal women with breast cancer. An approved bisph...
Eligibility Criteria
Inclusion
- Postmenopausal women, Stage III or axillary node positive
- Currently disease free of breast cancer and other invasive malignancies at the time of registration
- No concurrent use of bisphosphonates
Exclusion
- Metastatic disease
Key Trial Info
Start Date :
January 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT00213980
Start Date
January 1 2000
End Date
April 1 2008
Last Update
November 27 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin
Madison, Wisconsin, United States, 53792